Gossamer Bio, Inc

GOSSNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

488.8M

on 2026-06-30, from 226.2M on 2024-03-31 10-Q ↗

Newest

No limit

S-3ASR of 2026-01-28. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗

1 of its filings are not read yet.

Warrants

30.68M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

1.4 quarters

$57.0M on 2026-06-30 ÷ $40.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 2 of its filings are not read yet.

Also on file: $1K convertible notes, 2026-06-03 8-K ↗ · a 1-for-80 reverse split, 2026-09-10 8-K ↗